These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients. Khan S; Abuzakouk M; Doré PC; Sewell WA Ir J Med Sci; 2011 Mar; 180(1):125-8. PubMed ID: 21136195 [TBL] [Abstract][Full Text] [Related]
51. Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy. Mainra R; Xu Q; Chibbar R; Hassan A; Shoker A Transpl Immunol; 2013 Jun; 28(4):145-7. PubMed ID: 23685054 [TBL] [Abstract][Full Text] [Related]
52. Acute renal failure after large doses of intravenous immune globulin. Haskin JA; Warner DJ; Blank DU Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908 [TBL] [Abstract][Full Text] [Related]
53. Safety monitoring of the intravenous immunoglobulin preparation Intratect® in primary and secondary immunodeficiencies: a prospective non-interventional study. Bauhofer A; Dietrich RL; Schmeidl R Int J Clin Pharmacol Ther; 2015 Jan; 53(1):21-31. PubMed ID: 25345431 [TBL] [Abstract][Full Text] [Related]
54. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion. Welles CC; Tambra S; Lafayette RA Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320 [TBL] [Abstract][Full Text] [Related]
55. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ; Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164 [TBL] [Abstract][Full Text] [Related]
57. Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients. Foreman C; Russo P; Davies N; Hissaria P; Proudman S; Hughes T; Limaye V Intern Med J; 2017 Jan; 47(1):112-115. PubMed ID: 28076913 [TBL] [Abstract][Full Text] [Related]
58. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Bharath V; Eckert K; Kang M; Chin-Yee IH; Hsia CC Transfusion; 2015 Nov; 55(11):2597-605. PubMed ID: 26095012 [TBL] [Abstract][Full Text] [Related]
59. Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders. Broyles R; Rodden L; Riley P; Berger M Postgrad Med; 2013 Mar; 125(2):65-72. PubMed ID: 23816772 [TBL] [Abstract][Full Text] [Related]
60. Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience. Kaba S; Keskindemirci G; Aydogmus C; Siraneci R; Erol Cipe F Eur Ann Allergy Clin Immunol; 2017 Jan; 49(1):11-14. PubMed ID: 28120600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]